(Q52620208)
Statements
Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length. (English)
1 reference
R Ohno
1 reference
Y Kato
1 reference
E Nagura
1 reference
T Murase
1 reference
M Okumura
1 reference
H Yamada
1 reference
M Ogura
1 reference
S Minami
1 reference
H Suzuki
1 reference
Y Morishima
1 reference
1 December 1986
1 reference
4
1 reference
12
1 reference
1740-1747
1 reference